DESMOMED (Medsurge Pharma Pty Ltd)

Diabetes Insipidus

The treatment of ADH-sensitive cranial diabetes insipidus, including treatment of posthypophysectomy polydipsia and polyuria.

Nocturnal Enuresis

[TRADE NAME] Nasal Spray is indicated for the symptomatic treatment of primary nocturnal enuresis in patients who have normal ability to concentrate urine. [TRADE NAME] Nasal Spray should be used only in patients who are refractory to the enuresis alarm or in patients in whom enuresis alarm is contraindicated or inappropriate, and where the oral administration of desmopressin is not feasible.

Renal Concentrating Capacity

By intranasal administration to adults and children as a diagnostic test to establish renal concentrating capacity.